Results 1 to 10 of about 206 (67)
Neurological Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors
The use of immune checkpoint inhibitors (ICIs) for the treatment of various advanced and aggressive types of malignancy has significantly increased both survival and long-term remission rates.
Sotiria Stavropoulou De Lorenzo +9 more
doaj +3 more sources
Neurological Adverse Events Related to Immune Checkpoint Inhibitors: A Practical Review
The increasing use of immune checkpoint inhibitors (ICI) in cancer therapy has brought attention to their associated neurotoxicities, termed neurological immune-related adverse events (n-irAEs).
François Zammit, Emmanuel Seront
doaj +3 more sources
BackgroundImmune checkpoint inhibitor (ICI)-associated neurological immune-related adverse events (NAEs) are rare but serious side effects, of which autoimmune encephalitis (AIE) is a potentially fatal central nervous system disorder requiring more ...
Xiaomeng Di +3 more
doaj +3 more sources
Evaluation and management of acute high-grade immunotherapy-related neurotoxicity
Immune checkpoint inhibitor monoclonal antibodies allow the host's immune system to attack tumors, which has revolutionized cancer care over the last decade.
Marcelo Sandoval, MD +7 more
doaj +1 more source
BackgroundNeurological immune-related adverse events (irAE-n) are severe and potentially fatal toxicities of immune checkpoint inhibitors (ICI). To date, the clinical significance of neuronal autoantibodies in irAE-n is poorly understood.
Leonie Müller-Jensen +28 more
doaj +1 more source
Neurological adverse events associated with PD-1/PD-L1 immune checkpoint inhibitors
Immunotherapy is a promising method for cancer treatment. Among them, immune checkpoint inhibitors targeting PD-1/PD-L1 are increasingly used for certain cancers.
Yanting Zhou, Hongyan Li
doaj +1 more source
Background: Checkpoint inhibitors show impressive and durable responses in various cancer types and provide new avenues for cancer immunotherapy. However, these drugs have a variety of adverse events.
Saskia Bolz +11 more
doaj +1 more source
Cancer immunotherapy represents a novel anticancer strategy that acts directly on the immune system, promoting its activation toward cancer cells to enhance its natural ability to fight cancer.
Umberto Pensato +2 more
doaj +1 more source
Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of multiple malignancies, especially in non-small cell lung cancer (NSCLC). With the extensive application of ICIs in clinical practice, clinicians have to manage their toxicities ...
Ke Cheng +5 more
doaj +1 more source
Background: Along with the increasing use of immune checkpoint inhibitors comes a surge in immune-related toxicity. Here, we review the currently available data regarding neurological immune adverse events, and more specifically aseptic meningitis and ...
Laure Thouvenin +4 more
doaj +1 more source

